JUNE 2023LIFE SCIENCES REVIEW5Hong Ma, MD, Sr Vice President of Clinical Development, CARsgen TherapeuticsNovel Nanotechnology in CAR-T Therapy Targeting Solid Tumors18Kinga Bercsenyi, PhD, European Lead for Precision Medicine & Biomarker Solutions, Cerba ResearchWorldwide Patients' Access to Life-Changing Therapies24Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai LabAccelerating drug development of novel targeted therapies through histology-agnostic oncology clinical trials22Nelly Marmy Conus, DCT Manager, Decentralized Solutions, Syneos HealthSetting Up Organizations for Long-Term Follow-Up Studies26Erika Vento-Gaudens, Director, Global Clinical Trial Operations, Guardant HealthThe Rise in Outsourcing Clinical Trials2820Anna Cumaraswamy, Associate Director, Medical Affairs, Oncology, Gilead SciencesGilead Sciences: Driving innovative therapy for Canadian citizensWHAT'S HOT IN CANADIAN THERAPEUTICSCxO INSIGHTSCxO INSIGHTSCANADA: THE HOME TO ADVANCED THERAPEUTICS?16
< Page 4 | Page 6 >